Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model.
Ferrer-Lores B, Ortiz-Algarra A, Picó-Peris A, Estepa-Fernández A, Bellvís-Bataller F, Weiss GJ, Fuster-Matanzo A, Fernández JP, Jimenez-Pastor A, Hernani R, Saus-Carreres A, Benzaquen A, Ventura L, Piñana JL, Teruel AB, Serrano-Alcalá A, Dosdá R, Sopena-Novales P, Balaguer-Rosello A, Guerreiro M, Sanz J, Martí-Bonmatí L, Terol MJ, Alberich-Bayarri Á.
Ferrer-Lores B, et al. Among authors: ventura l.
EJNMMI Res. 2024 Nov 20;14(1):113. doi: 10.1186/s13550-024-01172-9.
EJNMMI Res. 2024.
PMID: 39567446
Free PMC article.